Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A pharmaceutical combination where hydroxypropyl methylcellulose (HPMC) serves as a polymer excipient and riboflavin (vitamin B2) is the active pharmaceutical ingredient. This combination is primarily used in gastric floating tablets for extended release, ophthalmic preparations, and advanced drug delivery systems. HPMC provides several functional benefits: - Controlled Release Matrix: Forms a gel barrier for sustained drug release - Film Coating: Protects the drug from environmental factors - Bioadhesive Properties: Improves adhesion in drug delivery systems - Thickening and Stabilizing: Enhances viscosity and prevents particle settling This combination offers several advantages: - Extended drug action time - Maintained stable blood drug concentration - Improved bioavailability - Lower toxicity and reduced side effects - In ophthalmic applications, it provides better corneal thickness maintenance
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on riboflavin + hydroxypropyl methylcellulose.